Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
WRAL Investigates: Why some veterinarians face minor charges for deadly mistakes
Recommended
When will the presidential race be called? Here's what to know.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Molecular Transport Inc
(NQ:
AMTI
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EST, Dec 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Applied Molecular Transport Inc
Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
December 27, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Molecular Transport Inc. - AMTI
November 28, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Applied Molecular Transport Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
October 03, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Molecular Transport Inc. - AMTI
September 27, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
September 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq – NXGN), Computer Task Group, Incorporated (Nasdaq -
September 21, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
AMTI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Applied Molecular Transport Inc. Is Fair to Shareholders
September 21, 2023
From
Halper Sadeh LLC
Via
Business Wire
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
September 21, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Applied Molecular Transport Reports Second Quarter 2023 Financial Results
August 14, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Reports First Quarter 2023 Financial Results
May 11, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic Alternatives
March 27, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 09, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 Congress
March 03, 2023
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
December 22, 2022
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of Pouchitis
November 10, 2022
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport to Present at Upcoming November Investor Conferences
November 08, 2022
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 07, 2022
From
Applied Molecular Transport Inc.
Via
GlobeNewswire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Applied Molecular Transport Inc. with Losses of $100,000 to Contact the Firm
July 11, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Applied Molecular Transport Inc. with Losses of $100,000 to Contact the Firm
July 10, 2022
From
The Schall Law Firm
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.